Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK

Movement Disorders

Volumn 15, Issue 1, 2000, Pages 18-23

  Chaudhuri, K Ray ^a,b,c   Hu, M T M ^a,b,d   Brooks, D J ^c,d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Afro Caribbean; Atypical; Indian; Levodopa hyporesponsive; Parkinsonism

Indexed keywords

LEVODOPA;

ADULT; AGED; BRADYKINESIA; CARIBBEAN ISLANDS; COGNITIVE DEFECT; DIABETES MELLITUS; DRUG EFFICACY; ETHNIC GROUP; GENETIC ANALYSIS; HUMAN; HYPERTENSION; INDIAN; MAJOR CLINICAL STUDY; NEGRO; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; UNITED KINGDOM;

EID: 0033976848     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200001)15:1<18::AID-MDS1005>3.0.CO;2-Z     Document Type: Review

References (35)

1. Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease in a Scottish city. BMJ 1986;292:534-536.
2. Office of Health Economics. Parkinson's Disease, vol 51. UK: Luton White Crescent, 1984:1-23.
3. Zhang Z, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.
4. Richards M, Ray Chaudhuri K. Parkinson's disease in populations of African origin: a review. Neuroepidemiology 1996;15:214-221.
5. Balarajan R, Idelstein AM, Bulusuy L, Shukla V. Patterns of mortality among migrants to England and Wales from the Indian subcontinent. BMJ 1995;311:1035-1036.
6. Dhawan J, Bray CL, Warburton R, Ghambir DS, Morris J. Insulin resistance, high prevalence of diabetes and cardiovascular risk in immigrant Asians. Genetic or environmental effect? Br Heart J 1994;72:413-421.
7. Chaturvedi N, McKeigue P, Marmot M. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension 1993;22:90-96.
8. Muwazi EMK, Trowell MC. Neurological diseases among African natives of Uganda: a review of 269 cases. East Afr Med J 1944; 21:2-19.
9. Rachman I. Neurological disorders in Rhodesia. In: Spillane JD, ed. Tropical Neurology. London: Oxford University Press, 1969: 237-246.
10. Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's disease in Benghazi, North-East Libya. Clin Neurol Neurosurg 1986;88:109-113.
11. Osuntukun BO, Adeuja AOG, Schoenberg BS, et al. Neurological disorders in Nigerian Africans: a community based study. Acta Neurol Scand 1987;75:13-21.
12. Kessler H. Epidemiological studies of Parkinson's disease. A community-based survey. Am J Epidemiol 1972;96:242-254.
13. Paddison RM, Parker Griffith R. Occurrence of Parkinson's disease in black patients at charity hospital in New Orleans. Neurology 1974;24:688-690.
14. Schoenberg BS, Osuntokun BO, Adeuja AOG, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria. Door-to-door community studies. Neurology 1988;38:645-646.
15. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease among middle-aged and elderly black Hispanic and white men and women in Northern Manhattan (1988-1993). Am J Epidemiol 1995;142:820-827.
16. Bharucha NE, Bharucha EP, Bharucha AE, Schoenberg BS. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988;49:400-409.
17. Roseman JM. Diabetes in black Americans. In: National Diabetes Data Group: Diabetes in America: Diabetes Data Compiled 1984. Washington, DC: US Government Printing Office, 1985. VIII-I-VIII (NIH Publication No. 85-1468).
18. Haerer AF, Anderson DW, Schoenberg BS. Prevalence of essential tremor: results from the Copiah County study. Arch Neurol 1992; 39:750-751.
19. Hornabrook RW, Nagurney JT. Essential tremor in Papua New Guinea. Brain 1976;99:659-672.
20. Storkey M. London's ethnic minorities. One city many communities. London Research Centre. 1991 Census. British Library, London.
21. Caparros-Lefebvre D, Elbaz A, Caribbean parkinsonism study group. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case control study. Lancet 1999;354:281-286.
22. Caparros-Lefebvre D, Lees A, Tolosa E. Pheneomenological study of parkinsonism in the French West Indies [Abstract]. Neurology 1999;52:A224.
23. McGreer PC, Schwab C, McGreer EG, Haddock RL, Steele JC. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Neurology 1998;49:400-409.
24. Ray Chaudhuri K, Richards M, Brooks DJ. Atypical parkinsonism in Afro-Caribbean and Asian populations in the UK [Abstract]. Mov Disord 1996;11:534.
25. Johnson MRD, Cross M, Cardew S. Inner city residents, ethnic minorities and primary health care. Postgrad Med J 1983;59:664-667.
26. Richards M, Brayne C, Forde C, Abas M, Levy R. Surveying African Caribbean elders in the community: implications for research on health and health service use. Int J Geriatr Psychiatry 1996;11:41-45.
27. Hu MTM, Richards M, Agapito C, Brooks D, Clough C, Ray Chaudhuri K. Parkinsonism in immigrant Afro-Caribbean and Indian subjects living in the United Kingdom. J Neurol Neurosurg Psychiatry 1999;66:258-259.
28. Parkes JD, Marsden CD, Rees JE, et al. Parkinson's disease, cerebral arteriosclerosis and senile dementia. Quarterly Journal of Medicine 1974;93:49-61.
29. Nagatsu T, Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 1988;87:178-182.
30. Booth RG, Castagnoli NJ, Rollema H. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives to MPTP/MPP+. Neurosci Lett 1989;100:306-312.
31. Cabedo N, Protais P, Cassels BK, Cortes D. Synthesis and dopamine receptor selectivity of the benzyl-tetrahydroisoquinoline(R)(+)nor-roefractine. J Nat Prod 1998;61:709-712.
32. Maruyama W, Narabayashi H, Dostert P, Naoi M. Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J Neural Transm 1996;103:1069-1076.
33. Blandina P, Cherici G, Moroni F, Prell GD, Green JP. Release of glutamate from striatum of freely moving rats by prosmethylimidazoleacetic acid. J Neurochem 1995;64:788-793.
34. Kunugi H, Nanko S, Ueki A, et al. High and low activity alleles of the COMT gene: ethnic differences and possible association with Parkinson's disease. Neurosci Lett 1997;221:202-204.
35. Hoda F, Nicoll D, Bennett P, et al. No association between Parkinson's disease and low activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun 1996;228:780-784.